ADR.eu

Language
  • About us
    • Who we are
    • Other domain disputes
    • Contact us
    • News
  • My disputes
    • Login
    • Register new user
  • Help
    • For Complainants
    • For Respondents
    • For Panelists
  • Resources
    • What is UDRP
    • Rules
    • Fees
    • Decisions
    • Panellists
    • Disputed Domain Names
  • Home

This site serves for these domain disputes:

generic Top Level Domains and .co.nl, .co.no and .sx domains

Back to entry page - choose type of domain name dispute

Search

Dispute 103674

  •  
    Complaint
    •  
      Complaint Suspended
    •  
      Dispute Terminated
  •  
    Decision
    •  
      Complaint Accepted
    •  
      Partially Accepted / Rejected
    •  
      Settlement
    •  
      Complaint Rejected
  •  
    Settlement
    •  
      Dispute Terminated

On-line ADR Center of the Czech Arbitration Court (CAC)

Panel Decision

§ 15 of the UDRP Rules (Rules), § 9 of the CAC’s Supplemental Rules (Supplemental Rules)

Case No. 103674
Time of Filing 2021-03-22 10:15:42
Disputed domain name BOEHRINGERINGELHEIMPETBATES.COM
Case Administrator
Name Denisa Rihova
Complainant
Organization Boehringer Ingelheim Pharma GmbH & Co.KG
Authorized Representative
Organization NAMESHIELD S.A.S.
Respondent
Organization Fundacion Comercio Electronico
Other Legal Proceedings
The Panel is not aware of any other legal proceedings related to the disputed domain name.
Identification of rights
Complainant owns a large portfolio of trademarks including the terms "BOEHRINGER INGELHEIM" in several countries, such as the international trademark BOEHRINGER-INGELHEIM® n°221544, registered since July 2nd, 1959
Factual Background
FACTS ASSERTED BY THE COMPLAINANT AND NOT CONTESTED BY THE RESPONDENT:

It is well-established that “a domain name that wholly incorporates a Complainant’s registered trademark may be sufficient to establish confusing similarity for purposes of the UDRP”(WIPO Case No. D2003-0888, Dr. Ing. h.c. F. Porsche AG v. Vasiliy Terkin).

The Complainant refers to decisions of past panels which have confirmed the notoriety of the trademark BOEHRINGER-INGELHEIM:

- WIPO Case No. D2019-0208, Boehringer Ingelheim Pharma GmbH & Co. KG v. Marius Graur (“Because of the very distinctive nature of the Complainant’s trademark [BOEHRINGER-INGELHEIM] and its widespread and longstanding use and reputation in the relevant field, it is inconceivable that the Respondent registered the disputed domain name without being aware of the Complainant’s legal rights.”);

- CAC Case No. 102274, BOEHRINGER INGELHEIM PHARMA GMBH & CO.KG v. Karen Liles (“In the absence of a response from Karen Liles and given the reputation of the Complainant and its trademark (see, among others, WIPO Case No. D2016-0021, Boehringer Ingelheim Pharma GmbH & Co.KG v. Kate Middleton), the Panel infers that the Respondent had the Complainant's trademarks BOEHRINGER-INGELHEIM in mind when registering the disputed domain name.”).

CAC Case No. 103124, Boehringer Ingelheim Pharma GmbH & Co.KG v. Fundacion Comercio Electronico <boehringeringelheimpetrreebates.com> (“The disputed domain name and the Complainant’s trademarks are very similar since they differ in a mere addition of misspelled version of a generic term “pet rebates" (i.e. addition of "PETRREEBATES") to the Complainant' trademark. This, however, cannot prevent the association in the eyes of internet consumers between the disputed domain name and the Complainant’s trademarks and thus the likelihood of confusion still exists. To conclude, addition of a non-distinctive term cannot sufficiently distinguish the disputed domain name from the Complainant’s trademarks.”).

- WIPO Case No. D2018-0497, StudioCanal v. Registration Private, Domains By Proxy, LLC / Sudjam Admin, Sudjam LLC (“In that circumstance, whether the commercial gain from misled Internet users is gained by the Respondent or by the Registrar (or by another third party), The Respondent controls and cannot (absent some special circumstance) disclaim responsibility for, the content appearing on the website to which the disputed domain name resolve […] so the Panel presumes that the Respondent has allowed the disputed domain name to be used with the intent to attract Internet users for commercial gain, by creating a likelihood of confusion with the Complainant's trademark as to the source, affiliation, or endorsement of the Respondent's website to which the disputed domain name resolves. Accordingly, the Panel finds that the disputed domain name was registered and is being used in bad faith.”).
 
NO ADMINISTRATIVELY COMPLAINT RESPONSE HAS BEEN FILED.

Rights
The Complainant has, to the satisfaction of the Panel, shown the disputed domain name is identical or confusingly similar to a trademark or service mark in which the Complainant has rights (within the meaning of paragraph 4(a)(i) of the Policy).
No rights or legitimate interests
The Complainant has, to the satisfaction of the Panel, shown the Respondent to have no rights or legitimate interests in respect of the disputed domain name (within the meaning of paragraph 4(a)(ii) of the Policy).
Bad faith
The Complainant has, to the satisfaction of the Panel, shown the disputed domain name has been registered and is being used in bad faith (within the meaning of paragraph 4(a)(iii) of the Policy).
Procedural Factors
The Panel is satisfied that all procedural requirements under UDRP were met and there is no other reason why it would be inappropriate to provide a decision.
Principal Reasons for the Decision
The domain name is confusingly similar to the protected trademark as a result of:

- the fact that the Complainant's trademark BOEHRINGER INGELHEIM(r) is included in its entirety in the domain name;
-the added term 'PET BATES' does not prevent the likelihood of confusion, but worsens it because of its directly misleading reference to the Complainant's website http://boehringeringelheimpetrebates.com, which is i.a. used to inform visitors of the website about offers for Pet medicines.

The Respondent has:
- no legitimate interest nor right in respect of the disputed domain name;
- registered and used the domain name in bad faith (by linking it to a parking page with commercial links).
Decision
For all the reasons stated above, the Complaint is Accepted
and the disputed domain name(s) is (are) to be
BOEHRINGERINGELHEIMPETBATES.COM Transferred to Boehringer Ingelheim Pharma GmbH & Co.KG
Panellists
Name Mr. E.J.V.T. van den Broek
Date of Panel Decision 2021-04-13
Publication of the Decision
Publish the Decision
Print this form

Copyright © 2008 Czech Arbitration Court | Online Platform: Copyright © 2008 Expert4me a.s. | Contact webmaster | Terms and Conditions | Privacy Policy | Contacts